Title : Second generation Abl kinase inhibitors and novel compounds to eliminate the Bcr-Abl/T315I clone.

Pub. Date : 2006 Nov

PMID : 18221045






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 To override resistance, several second generation ATP competitive Abl kinase inhibitors such as dasatinib, nilotinib and INNO-406 have been developed. bafetinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens